How does cAMP/protein kinase A signaling lead to tumors in the adrenal cortex and other tissues?
about
Differential PKA activation and AKAP association determines cell fate in cancer cellsThe Role of gsp Mutations on the Development of Adrenocortical Tumors and Adrenal HyperplasiaRecurrent activating mutation in PRKACA in cortisol-producing adrenal tumorsAdvances in targeting cyclic nucleotide phosphodiesterasesHuman adrenocortical carcinoma cell lines.Wnt/β-catenin signaling modulates human airway sensitization induced by β2-adrenoceptor stimulation.Cyclic nucleotide phosphodiesterases: important signaling modulators and therapeutic targets.Structural insights into mis-regulation of protein kinase A in human tumors.Protein kinase A activation enhances β-catenin transcriptional activity through nuclear localization to PML bodies.PRKACA: the catalytic subunit of protein kinase A and adrenocortical tumors.Activation of cyclic AMP signaling leads to different pathway alterations in lesions of the adrenal cortex caused by germline PRKAR1A defects versus those due to somatic GNAS mutationsProtein Kinase A Activation Promotes Cancer Cell Resistance to Glucose Starvation and AnoikisSteroidogenic Acute Regulatory Protein Overexpression Correlates with Protein Kinase A Activation in Adrenocortical Adenoma.Celecoxib reduces glucocorticoids in vitro and in a mouse model with adrenocortical hyperplasia.Comparison of the effects of PRKAR1A and PRKAR2B depletion on signaling pathways, cell growth, and cell cycle control of adrenocortical cellsPhosphodiesterases and adrenal Cushing in mice and humans.cAMP/PKA signaling defects in tumors: genetics and tissue-specific pluripotential cell-derived lesions in human and mouse.The transcriptome that mediates increased cyclic adenosine monophosphate signaling in PRKAR1A defects and other settings.Clinical and molecular genetics of the phosphodiesterases (PDEs).Loss of phosphodiesterase 4D mediates acquired triapine resistance via Epac-Rap1-Integrin signaling.A genetic and molecular update on adrenocortical causes of Cushing syndrome.FGFR1 and FGFR2 in fibrolamellar carcinoma.Bimodal antagonism of PKA signalling by ARHGAP36.Combined Use of Etomidate and Dexmedetomidine Produces an Additive Effect in Inhibiting the Secretion of Human Adrenocortical Hormones.A Role for Phosphodiesterase 11A (PDE11A) in the Formation of Social Memories and the Stabilization of Mood.Cyclic AMP-dependent protein kinase catalytic subunit A (PRKACA): the expected, the unexpected, and what might be next.Age-dependent effects of Armc5 haploinsufficiency on adrenocortical function.Microinsertions in PRKACA cause activation of the protein kinase A pathway in cardiac myxoma.The regulatory 1α subunit of protein kinase A modulates renal cystogenesis.Activating mutations of GNAS in canine cortisol-secreting adrenocortical tumors.Genetics: Pinpointing a hotspot in adrenal Cushing syndrome.The curious case of Gαs gain-of-function in neoplasia.
P2860
Q24337554-EA8BA437-BCB5-4B26-98A8-D30B0BFFA75CQ26741915-A1C2A37F-703D-493D-AFB9-796FDEB5D85CQ33820159-5752C3D0-275F-4B47-8C99-CC955B83C929Q34139490-72CB712F-41BB-4DB4-99A0-10D544326965Q34216956-B0B2F24C-1607-42AC-9A64-B37D658F0447Q34434700-6BD494F6-36CF-46A7-9C7D-7CCB130C2256Q34765802-5892899A-F4EC-4449-83E2-3AF239281376Q35062811-71CF0E33-23D5-46B5-90C2-FC1E50233545Q35316688-C622B1AE-877E-4655-B53A-B095111A0AC3Q35627125-CE272097-ECDF-497A-B422-B09B281D9296Q35869529-A0C2B2DD-04D6-4FED-9257-C5C912797279Q35957554-DBC6959B-B0F8-45AB-B5FB-C97AA70D6FA0Q36126238-DD2684E0-5032-4C05-A944-4C3C498F98FFQ36319490-280A0381-B8BC-42A2-89BD-B986E6C22451Q36503899-493CB001-EBDF-4042-ACDE-BA833AAD3F8AQ36514530-111B0196-0F53-47FD-8B2C-CCF60EEB7A6AQ36763148-7D943CA3-D36E-4764-B751-1C963F9BF995Q36838955-ED1A2CA0-A09A-4794-84C7-CE3EFD629647Q37657841-C59403F9-7FB0-4D40-AF54-6789E8EB3131Q37708984-1DE7FF59-A6E0-4AC8-8ED3-5E1655C47F08Q38769185-07427F15-8806-4BF9-B2DC-7FB104C22B05Q40640497-60EFE23A-0E21-439A-8DD9-0159337EA90EQ41431696-05DF7561-6920-4F5B-9BA2-302F51EAF4D4Q42485134-4F1989D3-A18B-4805-B212-7036D4C222B9Q47147373-4B65A9EF-CCA0-4A38-9E9A-ECDBB2575862Q47174516-1CA86AA0-5DB8-4E2C-B115-66E787C9A8CEQ47801106-CC4380C3-F1DB-49C4-862C-2B90F024A806Q48334823-DDACA829-CFA3-4939-9038-6B6AF041C62FQ50944400-15496AC9-AD82-4D3D-B508-158B15026CD6Q54240213-C56C97BC-08D1-4712-B6C9-51B5FB8C2675Q54345952-703F8F8A-08A4-4AA8-9EF2-2CC288E68363Q54955004-EEFD7489-269E-45BC-93F8-33259FC88114
P2860
How does cAMP/protein kinase A signaling lead to tumors in the adrenal cortex and other tissues?
description
2010 nî lūn-bûn
@nan
2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
How does cAMP/protein kinase A ...... enal cortex and other tissues?
@ast
How does cAMP/protein kinase A ...... enal cortex and other tissues?
@en
How does cAMP/protein kinase A ...... enal cortex and other tissues?
@nl
type
label
How does cAMP/protein kinase A ...... enal cortex and other tissues?
@ast
How does cAMP/protein kinase A ...... enal cortex and other tissues?
@en
How does cAMP/protein kinase A ...... enal cortex and other tissues?
@nl
prefLabel
How does cAMP/protein kinase A ...... enal cortex and other tissues?
@ast
How does cAMP/protein kinase A ...... enal cortex and other tissues?
@en
How does cAMP/protein kinase A ...... enal cortex and other tissues?
@nl
P2860
P1476
How does cAMP/protein kinase A ...... enal cortex and other tissues?
@en
P2093
Madson Q Almeida
P2860
P304
P356
10.1016/J.MCE.2010.11.018
P577
2010-11-25T00:00:00Z